言語を選択
新規登録

LRRC32 & Latent TGF-beta 3

お問い合わせ

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Dutogliptin TartrateREC-01; PHX-1149; PHX-1149TPhase 3 ClinicalPhenomixST Elevation Myocardial Infarction; Myocardial Infarction; Diabetes Mellitus, Type 2; Kidney Diseases; Leukemia, Myeloid, Acute
詳細
YogliptinPhase 3 ClinicalSichuan Sunheal Pharmaceutical Co Ltd, Chengdu Easton Biopharmaceuticals Co LtdDiabetes Mellitus, Type 2
詳細
CPL2009-0031Phase 3 ClinicalCadila Healthcare LtdDiabetes Mellitus, Type 2
詳細
Dapagliflozin formate/LinagliptinIN-C009; AJU-A51Phase 3 ClinicalHK inno.N Corporation, Aju Pharm Co LtdDiabetes Mellitus, Type 2
詳細
DA5221-B2DA5221-B2Phase 3 ClinicalDong-A ST Co LtdDiabetes Mellitus, Type 2
詳細
LID104LID104; LID-104Phase 3 ClinicalEmsDiabetes Mellitus, Type 2
詳細
TOTUM•63TOTUM-63Phase 3 ClinicalValbiotisDiabetes Mellitus, Type 2
詳細
Dapagliflozin/SitagliptinSID-1903; DW-6012Phase 3 ClinicalAstrazeneca SaDiabetes Mellitus, Type 2; ST Elevation Myocardial Infarction; Myocardial Infarction
詳細
TalabostatPT-100; BXCL-701Phase 2 ClinicalPoint TherapeuticsNeuroblastoma; Adenocarcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms, Germ Cell and Embryonal; Carcinoma, Small Cell; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Leukemia, Myeloid, Acute; Prostatic Neoplasms; Liver Neoplasms; Brain Neoplasms; Sarcoma; Neuroendocrine Tumors; Central Nervous System Neoplasms; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Skin Neoplasms; Myelodysplastic Syndromes; Kidney Neoplasms; Solid tumours; Ovarian Neoplasms
詳細
TQ-F3083TQ-F3083; CT-383Phase 2 ClinicalDiabetes Mellitus, Type 2; Diabetes Mellitus
詳細
BegelomabSAND-26; BT 5/9Phase 2 ClinicalAdienneDermatomyositis; Graft vs Host Disease
詳細
YS-110YSCMA; YS-110Phase 2 ClinicalY'S Therapeutics IncMesothelioma
詳細
SingletineDC-291407; DC-407; DC291407Phase 2 ClinicalCisen Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of SciencesDiabetes Mellitus, Type 2; Fatty Liver
詳細
GCP-002EP-HMRGPhase 2 ClinicalEsophageal Neoplasms
詳細
Metformin/Dapagliflozin/SitagliptinGMRx4Phase 2 ClinicalGeorge Medicines PTY Ltd, George Medicines UK LtdDiabetes Mellitus, Type 2
詳細
Bogliptin maleateHL012MAPhase 2 ClinicalShanghai Institute Of Materia Medica, Chinese Academy Of Sciences, East China University Of Science And Technology, Shandong Baiji Dichang Pharmaceutical Co LtdDiabetes Mellitus, Type 2
詳細
Augliptin HydrochloridePhase 1 ClinicalShanghai Sun-Sail Pharmaceutical Science & Technology Co Ltd, Nanjing Changao Pharmaceutical Science And Technologyco LtdDiabetes Mellitus, Type 2
詳細
Evogliptin TartrateLY-05007Phase 1 ClinicalDong-A Pharmaceutical Co LtdDiabetes Mellitus, Type 2
詳細
TQ-05510TQ-05510Phase 1 ClinicalDiabetes Mellitus, Type 2
詳細
Lobeglitazone/SitagliptinCKD-396Phase 1 ClinicalChong Kun Dang Pharmaceutical CorpDiabetes Mellitus, Type 2
詳細
Sitagliptin/TelmisartanHDDO-16091 + HDDO-16092; HOB-077; HDDO-1609Phase 1 ClinicalHyundai Pharmaceutical Co LtdHypertension; Diabetes Mellitus
詳細
TSL-0319TSL-0319Phase 1 ClinicalJiangsu Tasly Diyi Pharmaceutical Co LtdDiabetes Mellitus, Type 2
詳細
Linagliptin/Fimasartan Potassium TrihydratePhase 1 ClinicalBoryung Pharmaceutical Co LtdHypertension; Diabetes Mellitus
詳細
Retagliptin Phosphate/Metformin HydrochlorideHRX-0701Phase 1 ClinicalDiabetes Mellitus, Type 2
詳細
CGT-2201CGT-2201Phase 1 ClinicalCgenetech(Suzhou China) Co LtdDiabetes Mellitus, Type 2; Diabetes Mellitus
詳細
Empagliflozin/Metformin/Sitagliptin (Chong Kun Dang Pharmaceutical)CKD-379Phase 1 ClinicalChong Kun Dang Pharmaceutical CorpDiabetes Mellitus, Type 2
詳細
Empagliflozin/Metformin/Sitagliptin (Overseas Pharmaceuticals)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co LtdDiabetes Mellitus, Type 2
詳細
THDBH-100THDBH100; THDBH101Phase 1 ClinicalWuxi Apptec(Shanghai) Co LtdDiabetes Mellitus, Type 2
詳細
WXSHC-071WXSHC-071Phase 1 ClinicalDongbao Zixing (Hangzhou) Biological Medicine Co LtdDiabetes Mellitus, Type 2
詳細
REC-04ClinicalRecardio IncCardiovascular Diseases
詳細
Dutogliptin Tartrate/Metformin HydrochloridePhenomix Corporation
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Gemigliptin L-tartrate SesquihydrateLC-150444; LC-15-0444ApprovedLg Life Sciences LtdGemiglo, ZemigloSouth KoreaDiabetes Mellitus, Type 2Lg Life Sciences Ltd2012-06-27Diabetes Mellitus, Type 2; Hepatic Insufficiency
詳細
Gemigliptin L-tartrate Sesquihydrate/Metformin HydrochlorideApprovedLg Life Sciences LtdZemiMet SRSouth KoreaDiabetes Mellitus, Type 2Lg Life Sciences Ltd2015-01-01Diabetes Mellitus, Type 2
詳細
Teneligliptin Hydrobromide Hydrate/Metformin HydrochlorideApprovedHandok IncTenelia M SRSouth KoreaDiabetes Mellitus, Type 2Handok Inc2015-11-03Diabetes Mellitus, Type 2
詳細
EvogliptinDA-1229ApprovedDong-A Pharmaceutical Co LtdSuganon, SugarnonSouth KoreaDiabetes Mellitus, Type 2Dong-A Pharmaceutical Co Ltd2015-10-02Diabetes Mellitus, Type 2; Kidney Diseases; Aortic valve diseases; Liver Diseases
詳細
Saxagliptin HydrateBMS-477118; BMS-477118-11; OPC-262ApprovedBristol-Myers Squibb Company安立泽, OnglyzaEUDiabetes Mellitus, Type 2Astrazeneca Ab2009-07-31Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypoglycemia; Diabetes Mellitus
詳細
Teneligliptin Hydrobromide HydrateMP-513ApprovedMitsubishi Tanabe PharmaTenelia, TenglynJapanDiabetes Mellitus, Type 2Mitsubishi Tanabe Pharma, Daiichi Sankyo Co Ltd2012-06-29Diabetes Mellitus, Type 2
詳細
Retagliptin PhosphateSP-2086 PhosphateApproved瑞泽唐Mainland ChinaDiabetes Mellitus, Type 2Jiangsu Hengrui Medicine Co Ltd2023-06-27Diabetes Mellitus, Type 2; Renal Insufficiency; Diabetes Mellitus
詳細
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-ProlineMK-0431JApprovedMerck & Co Inc, Astellas Pharma IncSujanuJapanDiabetes Mellitus, Type 2null2018-03-23Diabetes Mellitus, Type 2
詳細
LinagliptinBI-1356; BI-1356-BSApprovedBoehringer Ingelheim Gmbh欧唐宁, Ondero, Trajenta, Trayenta, Trazenta, TradjentaUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim Gmbh2011-05-02Prediabetic State; Diabetes Mellitus, Type 2; Albuminuria; Renal Insufficiency; Schizophrenia; Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Hypertension; Endocrine System Diseases; Coronavirus Infections; Metabolic Diseases; Hepatic Insufficiency; Glucose Metabolism Disorders; Inflammation; Diabetes Mellitus; Ventricular Dysfunction, Left
詳細
Rosuvastatin Calcium/Gemigliptin L-tartrate SesquihydrateApprovedLg Life Sciences LtdZemiStatinDiabetes Mellitus, Type 2; Dyslipidemias
詳細
Alogliptin BenzoateSYR-322; TAK-322ApprovedTakedaNesina, 尼欣那, VipidiaJapanDiabetes Mellitus, Type 2Takeda2010-04-06Diabetes Mellitus, Type 2; Acute Coronary Syndrome; Diabetes Mellitus
詳細
Empagliflozin/Linagliptin/MetforminApprovedBoehringer Ingelheim Gmbh, Eli Lilly And CompanyTrijardy XRUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim Gmbh2020-01-27Diabetes Mellitus, Type 2
詳細
Sitagliptin Phosphate/Metformin HydrochlorideApprovedMerck & Co IncVelmetia, Janumet, 捷诺达, ZituvimetUnited StatesDiabetes Mellitus, Type 2Merck & Co Inc2007-03-30Diabetes Mellitus, Type 2
詳細
Teneligliptin Hydrobromide Hydrate/Canagliflozin HemihydrateApprovedMitsubishi Tanabe Pharma Corp, Daiichi Sankyo Co LtdCanaliaJapanDiabetes Mellitus, Type 2Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma2017-07-03Diabetes Mellitus, Type 2
詳細
Anagliptin/Metformin HydrochlorideSK-1501ApprovedSanwa Kagaku Kenkyusho Co Ltd, SuzukenMetoanaJapanDiabetes Mellitus, Type 2Sanwa Kagaku Kenkyusho Co Ltd2018-09-21Diabetes Mellitus, Type 2
詳細
Vildagliptin/Metformin HydrochlorideLMF-237ApprovedNovartis Pharma Ag宜合瑞, Eucreas, EquMet, Zomarist, IcandraEUDiabetes Mellitus, Type 2Novartis Europharm Ltd2007-11-14Diabetes Mellitus, Type 2
詳細
Cetagliptin PhosphateCGT-8012ApprovedCgenetech(Suzhou China) Co Ltd盛捷维Mainland ChinaDiabetes Mellitus, Type 2Cgenetech(Suzhou China) Co Ltd2024-12-01Diabetes Mellitus, Type 2
詳細
Alogliptin Benzoate/Metformin HydrochlorideCT-L01; CT-L-01ApprovedTakeda Pharmaceutical Co LtdVipdomet, Inisync, KazanoUnited StatesDiabetes Mellitus, Type 2Takeda Pharmaceuticals U.S.A. Inc2013-01-25Diabetes Mellitus, Type 2
詳細
CofrogliptinHSK7653; HSK-7653ApprovedLiaoning Haisco Pharmaceutical Co Ltd, Sichuan Haisco Pharmaceutical Co Ltd倍长平Mainland ChinaDiabetes Mellitus, Type 2Haisco Pharmaceutical Group Co Ltd2024-06-18Diabetes Mellitus, Type 2; Renal Insufficiency; Glucose Intolerance
詳細
AnagliptinSK-0403; CWP-0403ApprovedSanwa Kagaku Kenkyusho Co LtdSuiny, BeskoaJapanDiabetes Mellitus, Type 2null2012-09-28Diabetes Mellitus, Type 2
詳細
Dapagliflozin Propanediol Monohydrate/Saxagliptin HydrochlorideApprovedAstrazeneca PlcQternEUDiabetes Mellitus, Type 2Astrazeneca Ab2016-07-15Diabetes Mellitus, Type 2
詳細
Alogliptin Benzoate/Pioglitazone HydrochlorideSYR-322-4833 BLApprovedTakeda Pharmaceutical Co LtdNesinaact, Oseni, Liovel, IncresyncJapanDiabetes Mellitus, Type 2Takeda2011-07-01Diabetes Mellitus, Type 2
詳細
Sitagliptin Phosphate MonohydrateONO-5435A; ONO-5435; MK-0431; MK-431; L-000224715ApprovedMerck Sharp & Dohme CorpRistaben, Xelevia, Tesavel, Glactiv, 捷诺维, Januvia, DIABIT-IS XUnited StatesDiabetes Mellitus, Type 2Merck & Co Inc2006-10-16Myelodysplastic Syndromes; Hyperlipidemias; Kidney Failure, Chronic; Carcinoma, Hepatocellular; Diabetes Mellitus; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Renal Insufficiency, Chronic; Inflammation; Hepatitis C; Hepatic Insufficiency; Cardiovascular Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Psoriasis; Gastroparesis; HIV Infections; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Glucose Intolerance; Insulin Resistance; Atherosclerosis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Diabetes Mellitus, Type 2; Renal Insufficiency; Heart Failure; Leukemia, Myelogenous, Chronic; Cystic Fibrosis; Prediabetic State; Diabetes Mellitus, Type 1
詳細
Trelagliptin SuccinateTAK-472; SYR-472; SYR-111472; SYR-111472 succinateApprovedTakeda Pharmaceutical Co LtdZafatekJapanDiabetes Mellitus, Type 2Takeda2015-03-26Diabetes Mellitus, Type 2; Diabetes Mellitus
詳細
Evogliptin Tartrate/Metformin HydrochlorideDA-1229_01ApprovedDong-A Pharmaceutical Co LtdSugamet XRSouth KoreaDiabetes Mellitus, Type 2Dong-A Pharmaceutical Co Ltd2015-12-01Diabetes Mellitus, Type 2
詳細
Sitagliptin/ErtugliflozinApprovedPfizer IncSteglujanUnited StatesDiabetes Mellitus, Type 2Merck & Co Inc2017-12-19Diabetes Mellitus, Type 2
詳細
OmarigliptinMK-3102ApprovedMerck & Co IncMarizevJapanDiabetes Mellitus, Type 2Merck Sharp & Dohme Corp2015-09-28Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Diabetes Mellitus
詳細
Teneligliptin/PioglitazoneApprovedGlenmark Pharmaceuticals LtdZita Plus PioIndiaDiabetes Mellitus, Type 2Glenmark Pharmaceuticals Ltd2022-04-25Diabetes Mellitus, Type 2
詳細
Metformin Hydrochloride/Sitagliptin HydrochlorideApprovedSandoz BvEUSandoz Bv2019-12-10Diabetes Mellitus, Type 2
詳細
Sitagliptin TartrateApprovedHeumann Pharma GmbH & Co Generica KGSitagliptin Heumann 25 mg FilmtablettenEUHeumann Pharma GmbH & Co Generica KG2020-12-14Diabetes Mellitus, Type 1; Parkinson Disease; Diabetic Nephropathies
詳細
Sitagliptin HydrochlorideApprovedLaboratorios Alter SaSpainDiabetes Mellitus, Type 2Laboratorios Alter Sa2019-03-06Diabetes Mellitus, Type 2; Polycystic Ovary Syndrome
詳細
GemigliptinApproved
詳細
Linagliptin/Metformin HydrochlorideGC2129A; GC-2129-A; DW6013ApprovedBoehringer Ingelheim GmbhJentadueto Xr, Trajenta Duo, Jentadueto, 欧双宁United StatesDiabetes Mellitus, Type 2Boehringer Ingelheim Gmbh2012-01-30Diabetes Mellitus, Type 2
詳細
Linagliptin/EmpagliflozinBI 1356/BI 10773; BI 10773/linagliptin; BI 1356/empagliflozin; Empagliflozin/BI 1356; Linagliptin/BI 10773; BI 10773/BI 1356ApprovedC.H. Boehringer Sohn Ag & Co. KgTradiance, Glyxambi, EsgliteoUnited StatesDiabetes Mellitus, Type 2Boehringer Ingelheim Gmbh2015-01-30Diabetes Mellitus, Type 2; Cardiovascular Diseases
詳細
VildagliptinLAF-237; DSP-7238; LAF-237A; NVP-LAF-237ApprovedNovartis Pharma Ag佳维乐, Equa, Jalra, Galvus, Gliptus, XiliarxEUDiabetes Mellitus, Type 2Novartis Europharm Ltd2007-09-25Prediabetic State; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Renal Insufficiency; Schizophrenia; Kidney Diseases; Insulin Resistance; Dyslipidemias; Diabetes, Gestational; Diabetes Mellitus
詳細
Saxagliptin Hydrochloride/Metformin HydrochlorideApprovedAstrazeneca Plc安立格, Kombiglyze Xr, KomboglyzeEUDiabetes Mellitus, Type 2Astrazeneca Ab2010-11-05Diabetes Mellitus, Type 2
詳細
  • お問い合わせ
  • 市販薬剤に関する情報
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8